发明名称 |
CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING |
摘要 |
<p>Disclosed herein are CMV vectors that include a heterologous protein antigen, an active UL131 protein (or an ortholog thereof), an active UL128 protein (or an ortholog thereof), but wherein the CMV vector lacks an active UL130 protein (or an ortholog thereof). Also disclosed herein are CMV vectors comprising: a heterologous protein antigen, an active UL131 protein (or an ortholog thereof), an active UL130 protein (or an ortholog thereof), but wherein the CMV vector lacks an active UL128 protein. Further disclosed are methods of using CMV vectors to generate an immune response characterized as having at least 10% of the CD8+ T cells directed against epitopes presented by MHC Class II.</p> |
申请公布号 |
CA2904001(A1) |
申请公布日期 |
2014.09.12 |
申请号 |
CA20142904001 |
申请日期 |
2014.03.05 |
申请人 |
OREGON HEALTH & SCIENCE UNIVERSITY |
发明人 |
PICKER, LOUIS;HANSEN, SCOTT;FRUEH, KLAUS;MALOULI, DANIEL |
分类号 |
C12N15/86;A61K48/00;C12N15/12 |
主分类号 |
C12N15/86 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|